Drugdevelopment-technology.com

BAGNEUX, France, April 9, 2015 (GLOBE NEWSWIRE) — DBV Technologies Receives FDA Breakthrough Therapy Designation for Viaskin Peanut for the Treatment of Peanut Allergy in Children DBV Technologies is the first company to announce Breakthrough Therapy...

Dermira, a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and their patients, announced positive Phase IIb study results for DRM04, its proprietary topical anticholinergic product, in...

Consensus on the Development of Vaccines against Naturally Acquired Melioidosis - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC Volume 21, Number 6—June 2015 Online Report Consensus on the Development of Vaccines against...

Anatomy Integrity of long thoracic nerve after damage due to surgery can be tested bedside by asking patient to raise the arm above the head on the affected side. Inhaled foreign body is likely to lodge in right lung because of reasons that right principal...

by John Otrompke, with Cheryl Scott and S. Anne Montgomery When the United States Food and Drug Administration (FDA) approved the country’s first ever biosimilar on 6 March 2015, it had been a long time coming. After all, the European Union had approved...